{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:53:39Z","timestamp":1790711619970,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Blood-based biomarkers (BBM) are becoming easily detectable tools to reveal pathological changes in Alzheimer\u2019s disease (AD). A comprehensive and up-to-date overview of the association between BBM and brain MRI parameters is not available. This systematic review aimed to summarize the literature on the associations between the main BBM and MRI markers across the clinical AD continuum. A systematic literature search was carried out on PubMed and Web of Science and a total of 33 articles were included. Hippocampal volume was positively correlated with A\u03b242 and A\u03b242\/A\u03b240 and negatively with A\u03b240 plasma levels. P-tau181 and p-tau217 concentrations were negatively correlated with temporal grey matter volume and cortical thickness. NfL levels were negatively correlated with white matter microstructural integrity, whereas GFAP levels were positively correlated with myo-inositol values in the posterior cingulate cortex\/precuneus. These findings highlight consistent associations between various BBM and brain MRI markers even in the pre-clinical and prodromal stages of AD. This suggests a possible advantage in combining multiple AD-related markers to improve accuracy of early diagnosis, prognosis, progression monitoring and treatment response.<\/jats:p>","DOI":"10.1007\/s00415-024-12674-w","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T13:06:04Z","timestamp":1726146364000},"page":"7120-7140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association between blood-based protein biomarkers and brain MRI in the Alzheimer\u2019s disease continuum: a systematic review"],"prefix":"10.1007","volume":"271","author":[{"given":"Micaela","family":"Mitolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1715-6442","authenticated-orcid":false,"given":"Riccardo","family":"Manca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Nacmias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalena","family":"Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"4","key":"12674_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","volume":"23","author":"A Bradford","year":"2009","unstructured":"Bradford A, Kunik ME, Schulz P, Williams SP, Singh H (2009) Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord 23(4):306\u2013314","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"12674_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach TG, Monsell SE, Phillips LE, Kukull W (2012) Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005\u20132010. J Neuropathol Exp Neurol 71(4):266\u2013273","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"12674_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269","journal-title":"Alzheimers Dement"},{"issue":"6","key":"12674_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","volume":"15","author":"A Vergallo","year":"2019","unstructured":"Vergallo A, M\u00e9gret L, Lista S, Cavedo E, Zetterberg H, Blennow K et al (2019) Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease. Alzheimers Dement 15(6):764\u2013775","journal-title":"Alzheimers Dement"},{"issue":"5","key":"12674_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.25334","volume":"84","author":"IMW Verberk","year":"2018","unstructured":"Verberk IMW, Slot RE, Verfaillie SCJ, Heijst H, Prins ND, van Berckel BNM et al (2018) Plasma amyloid as prescreener for the earliest Alzheimer pathological changes. Ann Neurol 84(5):648\u2013658","journal-title":"Ann Neurol"},{"issue":"3","key":"12674_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-190533","volume":"71","author":"P Chatterjee","year":"2019","unstructured":"Chatterjee P, Elmi M, Goozee K, Shah T, Sohrabi HR, Dias CB et al (2019) Ultrasensitive detection of plasma amyloid-\u03b2 as a biomarker for cognitively normal elderly individuals at risk of Alzheimer\u2019s disease. J Alzheimers Dis 71(3):775\u2013783","journal-title":"J Alzheimers Dis"},{"key":"12674_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2023.100063","volume":"8","author":"JE Georgakas","year":"2023","unstructured":"Georgakas JE, Howe MD, Thompson LI, Riera NM, Riddle MC (2023) Biomarkers of Alzheimer\u2019s disease: Past, present and future clinical use. Biomark Neuropsychiatry 8:100063","journal-title":"Biomark Neuropsychiatry"},{"issue":"4","key":"12674_CR8","first-page":"569","volume":"9","author":"D Angioni","year":"2022","unstructured":"Angioni D, Delrieu J, Hansson O, Fillit H, Aisen P, Cummings J et al (2022) Blood biomarkers from research use to clinical practice: what must be done? A report from the EU\/US CTAD task force. J Prev Alzheimers Dis 9(4):569\u2013579","journal-title":"J Prev Alzheimers Dis"},{"issue":"9","key":"12674_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel H, Cummings J, Blennow K, Gao P, Jack CR, Vergallo A (2021) Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol 17(9):580\u2013589","journal-title":"Nat Rev Neurol"},{"key":"12674_CR10","doi-asserted-by":"publisher","first-page":"683689","DOI":"10.3389\/fnagi.2022.683689","volume":"14","author":"A Hardy-Sosa","year":"2022","unstructured":"Hardy-Sosa A, Le\u00f3n-Arcia K, Llibre-Guerra JJ, Berlanga-Acosta J, Baez SDLC, Guillen-Nieto G et al (2022) Diagnostic accuracy of blood-based biomarker panels: a systematic review. Front Aging Neurosci 14:683689","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"12674_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8392","volume":"5","author":"Y Hu","year":"2022","unstructured":"Hu Y, Kirmess KM, Meyer MR, Rabinovici GD, Gatsonis C, Siegel BA et al (2022) Assessment of a plasma amyloid probability score to estimate amyloid positron emission tomography findings among adults with cognitive impairment. JAMA Netw Open 5(4):e228392","journal-title":"JAMA Netw Open"},{"issue":"1","key":"12674_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-021-00451-6","volume":"16","author":"T West","year":"2021","unstructured":"West T, Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y et al (2021) A blood-based diagnostic test incorporating plasma A\u03b242\/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. Mol Neurodegener 16(1):30","journal-title":"Mol Neurodegener"},{"issue":"17","key":"12674_CR13","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA et al (2019) High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 93(17):e1647\u2013e1659","journal-title":"Neurology"},{"issue":"5","key":"12674_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G et al (2021) Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol 141(5):709\u2013724","journal-title":"Acta Neuropathol"},{"issue":"2","key":"12674_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/YCO.0000000000000851","volume":"36","author":"WG Balogun","year":"2023","unstructured":"Balogun WG, Zetterberg H, Blennow K, Karikari TK (2023) Plasma biomarkers for neurodegenerative disorders: ready for prime time? Curr Opin Psychiatry 36(2):112\u2013118","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"12674_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-021-00234-5","volume":"10","author":"X Ding","year":"2021","unstructured":"Ding X, Zhang S, Jiang L, Wang L, Li T, Lei P (2021) Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer\u2019s disease: a systematic review and meta-analysis. Transl Neurodegener 10(1):10","journal-title":"Transl Neurodegener"},{"issue":"1","key":"12674_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","volume":"18","author":"F Gonzalez-Ortiz","year":"2023","unstructured":"Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK (2023) Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications. Mol Neurodegener 18(1):18","journal-title":"Mol Neurodegener"},{"issue":"2","key":"12674_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00702-022-02471-y","volume":"129","author":"F Verde","year":"2022","unstructured":"Verde F (2022) Tau proteins in blood as biomarkers of Alzheimer\u2019s disease and other proteinopathies. J Neural Transm (Vienna) 129(2):239\u2013259","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"12674_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E et al (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer Disease vs other neurodegenerative disorders. JAMA 324(8):772\u2013781","journal-title":"JAMA"},{"key":"12674_CR20","doi-asserted-by":"crossref","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonatis E et al (2023) Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer's disease pathology. medRxiv 2023.07.11.23292493","DOI":"10.1101\/2023.07.11.23292493"},{"issue":"10","key":"12674_CR21","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1002\/alz.13393","volume":"19","author":"PCL Ferreira","year":"2023","unstructured":"Ferreira PCL, Therriault J, Tissot C, Ferrari-Souza JP, Benedet AL, Povala G et al (2023) Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals. Alzheimers Dement 19(10):4463\u20134474","journal-title":"Alzheimers Dement"},{"issue":"2","key":"12674_CR22","doi-asserted-by":"publisher","first-page":"fcad057","DOI":"10.1093\/braincomms\/fcad057","volume":"5","author":"EM Jonaitis","year":"2023","unstructured":"Jonaitis EM, Janelidze S, Cody KA, Langhough R, Du L, Chin NA et al (2023) Plasma phosphorylated tau 217 in preclinical Alzheimer\u2019s disease. Brain Commun 5(2):fcad057","journal-title":"Brain Commun"},{"issue":"3","key":"12674_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/nan.12378","volume":"43","author":"H Zetterberg","year":"2017","unstructured":"Zetterberg H (2017) Review: Tau in biofluids - relation to pathology, imaging and clinical features. Neuropathol Appl Neurobiol 43(3):194\u2013199","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"10","key":"12674_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.7326\/M19-3888","volume":"172","author":"HA Fink","year":"2020","unstructured":"Fink HA, Linskens EJ, Silverman PC, McCarten JR, Hemmy LS, Ouellette JM et al (2020) Accuracy of biomarker testing for neuropathologically defined Alzheimer disease in older adults with dementia. Ann Intern Med 172(10):669\u2013677","journal-title":"Ann Intern Med"},{"issue":"17","key":"12674_CR25","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.18632\/aging.102220","volume":"11","author":"H Hu","year":"2019","unstructured":"Hu H, Chen K, Ou Y, Cao X, Chen S, Cui M et al (2019) Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults. Aging (Albany NY) 11(17):6904\u20136914","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"12674_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 74(5):557\u2013566","journal-title":"JAMA Neurol"},{"issue":"9","key":"12674_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028932","volume":"101","author":"J Zhang","year":"2022","unstructured":"Zhang J, Cheng H, Liu W, Li H, Song Y, Jia L (2022) Neurofilament light chain in cerebrospinal fluid or blood as a biomarker for mild cognitive impairment: a systematic review and meta-analysis. Medicine (Baltimore) 101(9):e28932","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"12674_CR28","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1007\/s12035-020-02035-9","volume":"57","author":"G Palermo","year":"2020","unstructured":"Palermo G, Mazzucchi S, Della Vecchia A, Siciliano G, Bonuccelli U, Azuar C et al (2020) Different clinical contexts of use of blood neurofilament light chain protein in the spectrum of neurodegenerative diseases. Mol Neurobiol 57(11):4667\u20134691","journal-title":"Mol Neurobiol"},{"issue":"9","key":"12674_CR29","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cells12091309","volume":"12","author":"KY Kim","year":"2023","unstructured":"Kim KY, Shin KY, Chang K (2023) GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells 12(9):1309","journal-title":"Cells"},{"issue":"4","key":"12674_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562","journal-title":"Alzheimers Dement"},{"issue":"9","key":"12674_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","volume":"15","author":"J Yu","year":"2019","unstructured":"Yu J, Li J, Suckling J, Feng L, Pan A, Wang Y et al (2019) Frequency and longitudinal clinical outcomes of Alzheimer\u2019s AT(N) biomarker profiles: a longitudinal study. Alzheimers Dement 15(9):1208\u20131217","journal-title":"Alzheimers Dement"},{"key":"12674_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/psyrad\/kkad009","volume":"3","author":"C Dang","year":"2023","unstructured":"Dang C, Wang Y, Li Q, Lu Y (2023) Neuroimaging modalities in the detection of Alzheimer\u2019s disease-associated biomarkers. Psychoradiology 3:1\u201317","journal-title":"Psychoradiology"},{"issue":"9","key":"12674_CR33","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/gerona\/glw022","volume":"71","author":"JL Cantero","year":"2016","unstructured":"Cantero JL, Iglesias JE, Van Leemput K, Atienza M (2016) Regional hippocampal atrophy and higher levels of plasma amyloid-beta are associated with subjective memory complaints in nondemented elderly subjects. J Gerontol A Biol Sci Med Sci 71(9):1210\u20131215","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"12674_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-210344","volume":"82","author":"C Mao","year":"2021","unstructured":"Mao C, Sha L, Li J, Huang X, Chu S, Lei D et al (2021) Relationship between general cognition, visual assessed cortical atrophy, and cerebrospinal fluid biomarkers in Alzheimer\u2019s Disease: A cross-sectional study from a Chinese PUMCH cohort. J Alzheimers Dis 82(1):205\u2013214","journal-title":"J Alzheimers Dis"},{"key":"12674_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105662","volume":"166","author":"KL Meeker","year":"2022","unstructured":"Meeker KL, Butt OH, Gordon BA, Fagan AM, Schindler SE, Morris JC et al (2022) Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage. Neurobiol Dis 166:105662","journal-title":"Neurobiol Dis"},{"issue":"2","key":"12674_CR36","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3233\/JAD-180676","volume":"66","author":"L M\u00fcller-Ehrenberg","year":"2018","unstructured":"M\u00fcller-Ehrenberg L, Riphagen JM, Verhey FRJ, Sack AT, Jacobs HIL (2018) Alzheimer\u2019s Disease biomarkers have distinct associations with specific hippocampal subfield volumes. J Alzheimers Dis 66(2):811\u2013823","journal-title":"J Alzheimers Dis"},{"key":"12674_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.01.013","volume":"53","author":"PJ Nathan","year":"2017","unstructured":"Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C et al (2017) Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiol Aging 53:1\u201310","journal-title":"Neurobiol Aging"},{"key":"12674_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.906519","volume":"14","author":"M Wan","year":"2022","unstructured":"Wan M, Liu H, Liu X, Zhang W, Xiao X, Zhang S et al (2022) Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer\u2019s disease. Front Aging Neurosci 14:906519","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"12674_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3233\/JAD-181210","volume":"70","author":"KH Alm","year":"2019","unstructured":"Alm KH, Bakker A (2019) Relationships between diffusion tensor imaging and cerebrospinal fluid metrics in early stages of the Alzheimer\u2019s disease continuum. J Alzheimers Dis 70(4):965\u2013981","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"12674_CR40","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.1111\/ejn.15860","volume":"56","author":"T Qiu","year":"2022","unstructured":"Qiu T, Zeng Q, Zhang Y, Luo X, Xu X, Li X et al (2022) Altered functional connectivity pattern of hippocampal subfields in individuals with objectively-defined subtle cognitive decline and its association with cognition and cerebrospinal fluid biomarkers. Eur J Neurosci 56(12):6227\u20136238","journal-title":"Eur J Neurosci"},{"issue":"6","key":"12674_CR41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1503\/jpn.160190","volume":"42","author":"M Weiler","year":"2017","unstructured":"Weiler M, de Campos BM, Teixeira CVDL, Casseb RF, Carletti-Cassani AFMK, Vicentini JE et al (2017) Intranetwork and internetwork connectivity in patients with Alzheimer disease and the association with cerebrospinal fluid biomarker levels. J Psychiatry Neurosci 42(6):366\u2013377","journal-title":"J Psychiatry Neurosci"},{"issue":"10","key":"12674_CR42","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.acra.2020.06.006","volume":"28","author":"AD Piersson","year":"2021","unstructured":"Piersson AD, Mohamad M, Rajab F, Suppiah S (2021) Cerebrospinal fluid amyloid beta, tau levels, apolipoprotein, and 1H-MRS brain metabolites in Alzheimer\u2019s disease: a systematic review. Acad Radiol 28(10):1447\u20131463","journal-title":"Acad Radiol"},{"issue":"6","key":"12674_CR43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12264-022-00836-7","volume":"38","author":"S Huang","year":"2022","unstructured":"Huang S, Wang Y, Guo J (2022) Biofluid biomarkers of Alzheimer\u2019s Disease: Progress, problems, and perspectives. Neurosci Bull 38(6):677\u2013691","journal-title":"Neurosci Bull"},{"issue":"12","key":"12674_CR44","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL, Mil\u00e0-Alom\u00e0 M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F et al (2021) Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer Disease continuum. JAMA Neurol 78(12):1471\u20131483","journal-title":"JAMA Neurol"},{"issue":"7","key":"12674_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.12283","volume":"17","author":"J Simr\u00e9n","year":"2021","unstructured":"Simr\u00e9n J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J et al (2021) The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease. Alzheimers Dement 17(7):1145\u20131156","journal-title":"Alzheimers Dement"},{"key":"12674_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"6","key":"12674_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L et al (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28(6):595\u2013599","journal-title":"Nat Biotechnol"},{"issue":"4","key":"12674_CR48","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JAD-141041","volume":"42","author":"SE O'Bryant","year":"2014","unstructured":"O\u2019Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X et al (2014) Validation of a serum screen for Alzheimer\u2019s disease across assay platforms, species, and tissues. J Alzheimers Dis 42(4):1325\u20131335","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"12674_CR49","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jalz.2018.01.004","volume":"14","author":"O Hanon","year":"2018","unstructured":"Hanon O, Vidal J, Lehmann S, Bombois S, Allinquant B, Tr\u00e9luyer J et al (2018) Plasma amyloid levels within the Alzheimer\u2019s process and correlations with central biomarkers. Alzheimers Dement 14(7):858\u2013868","journal-title":"Alzheimers Dement"},{"issue":"1","key":"12674_CR50","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1038\/s41598-017-05390-1","volume":"7","author":"J Hsu","year":"2017","unstructured":"Hsu J, Lee W, Liao Y, Lirng J, Wang S, Fuh J (2017) Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer\u2019s disease. Sci Rep 7(1):5035","journal-title":"Sci Rep"},{"issue":"9","key":"12674_CR51","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamaneurol.2021.2293","volume":"78","author":"MM Mielke","year":"2021","unstructured":"Mielke MM, Frank RD, Dage JL, Jeromin A, Ashton NJ, Blennow K et al (2021) Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes. JAMA Neurol 78(9):1108\u20131117","journal-title":"JAMA Neurol"},{"issue":"8","key":"12674_CR52","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114398","volume":"13","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele R, Reimand J, Smith R, Leuzy A, Strandberg O, Palmqvist S et al (2021) Tau PET correlates with different Alzheimer\u2019s disease-related features compared to CSF and plasma p-tau biomarkers. EMBO Mol Med 13(8):e14398","journal-title":"EMBO Mol Med"},{"issue":"3","key":"12674_CR53","doi-asserted-by":"publisher","first-page":"fcac135","DOI":"10.1093\/braincomms\/fcac135","volume":"4","author":"N Spotorno","year":"2022","unstructured":"Spotorno N, Najac C, Stomrud E, Mattsson-Carlgren N, Palmqvist S, van Westen D et al (2022) Astrocytic function is associated with both amyloid-\u03b2 and tau pathology in non-demented APOE \u03f54 carriers. Brain Commun 4(3):fcac135","journal-title":"Brain Commun"},{"issue":"1","key":"12674_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JAD-221001","volume":"93","author":"C Krebs","year":"2023","unstructured":"Krebs C, Brill E, Minkova L, Federspiel A, Kellner-Weldon F, Wyss P et al (2023) Investigating compensatory brain activity in older adults with subjective cognitive decline. J Alzheimers Dis 93(1):107\u2013124","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"12674_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1567205013666151218150202","volume":"13","author":"A Poljak","year":"2016","unstructured":"Poljak A, Crawford JD, Smythe GA, Brodaty H, Slavin MJ, Kochan NA et al (2016) The relationship between plasma A\u03b2 levels, cognitive function and brain volumetrics: sydney memory and ageing study. Curr Alzheimer Res 13(3):243\u2013255","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"12674_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1212\/01.wnl.0000191403.95453.6a","volume":"66","author":"ME Gurol","year":"2006","unstructured":"Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T et al (2006) Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66(1):23\u201329","journal-title":"Neurology"},{"key":"12674_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2018.00175","volume":"10","author":"L Fan","year":"2018","unstructured":"Fan L, Tzen K, Chen Y, Chen T, Lai Y, Yen R et al (2018) The relation between brain amyloid deposition, cortical atrophy, and plasma biomarkers in amnesic mild cognitive impairment and Alzheimer\u2019s Disease. Front Aging Neurosci 10:175","journal-title":"Front Aging Neurosci"},{"issue":"5\u20138","key":"12674_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-014-0056-3","volume":"6","author":"O Sotolongo-Grau","year":"2014","unstructured":"Sotolongo-Grau O, Pesini P, Valero S, Lafuente A, Buend\u00eda M, P\u00e9rez-Grijalba V et al (2014) Association between cell-bound blood amyloid-\u03b2(1\u201340) levels and hippocampus volume. Alzheimers Res Ther 6(5\u20138):56","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"12674_CR59","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1093\/brain\/awac138","volume":"145","author":"SS Shahid","year":"2022","unstructured":"Shahid SS, Wen Q, Risacher SL, Farlow MR, Unverzagt FW, Apostolova LG et al (2022) Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer\u2019s disease. Brain 145(6):2149\u20132160","journal-title":"Brain"},{"key":"12674_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.592024","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Zhao M, Lin L, Han Y (2021) Plasma \u03b2-amyloid levels associated with structural integrity based on diffusion tensor imaging in subjective cognitive decline: the SILCODE study. Front Aging Neurosci 12:592024","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"12674_CR61","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL et al (2020) Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol 19(5):422\u2013433","journal-title":"Lancet Neurol"},{"issue":"2","key":"12674_CR62","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","volume":"26","author":"TK Karikari","year":"2021","unstructured":"Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Su\u00e1rez-Calvet M et al (2021) Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer\u2019s Disease Neuroimaging Initiative. Mol Psychiatry 26(2):429\u2013442","journal-title":"Mol Psychiatry"},{"issue":"3","key":"12674_CR63","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s11011-022-00908-7","volume":"37","author":"F Nabizadeh","year":"2022","unstructured":"Nabizadeh F, Pourhamzeh M, Khani S, Rezaei A, Ranjbaran F, Deravi N (2022) Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer\u2019s disease progression. Metab Brain Dis 37(3):761\u2013771","journal-title":"Metab Brain Dis"},{"issue":"9","key":"12674_CR64","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A et al (2021) Association of plasma p-tau217 and p-tau181 with clinical phenotype, neuropathology, and imaging markers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol 20(9):739\u2013752","journal-title":"Lancet Neurol"},{"issue":"6","key":"12674_CR65","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jnnp-2022-330619","volume":"94","author":"D Altomare","year":"2023","unstructured":"Altomare D, Stampacchia S, Ribaldi F, Tomczyk S, Chevalier C, Poulain G et al (2023) Plasma biomarkers for Alzheimer\u2019s disease: a field-test in a memory clinic. J Neurol Neurosurg Psychiatry 94(6):420\u2013427","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"12674_CR66","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13195-021-00944-y","volume":"13","author":"JD Marks","year":"2021","unstructured":"Marks JD, Syrjanen JA, Graff-Radford J, Petersen RC, Machulda MM, Campbell MR et al (2021) Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes. Alzheimers Res Ther 13(1):199","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"12674_CR67","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1017\/S1355617721000813","volume":"28","author":"BM Asken","year":"2022","unstructured":"Asken BM, VandeVrede L, Rojas JC, Fonseca C, Staffaroni AM, Elahi FM et al (2022) Lower white matter volume and worse executive functioning reflected in higher levels of plasma GFAP among older adults with and without cognitive impairment. J Int Neuropsychol Soc 28(6):588\u2013599","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"12674_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-200901","volume":"79","author":"W Barker","year":"2021","unstructured":"Barker W, Quinonez C, Greig MT, Behar R, Chirinos C, Rodriguez RA et al (2021) Utility of plasma neurofilament light in the 1Florida Alzheimer\u2019s Disease Research Center (ADRC). J Alzheimers Dis 79(1):59\u201370","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"12674_CR69","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1212\/WNL.0000000000011226","volume":"96","author":"I Ill\u00e1n-Gala","year":"2021","unstructured":"Ill\u00e1n-Gala I, Lleo A, Karydas A, Staffaroni AM, Zetterberg H, Sivasankaran R et al (2021) Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer Disease. Neurology 96(5):e671\u2013e683","journal-title":"Neurology"},{"issue":"13","key":"12674_CR70","doi-asserted-by":"publisher","first-page":"e1315","DOI":"10.1212\/WNL.0000000000200035","volume":"98","author":"JL Ebenau","year":"2022","unstructured":"Ebenau JL, Pelkmans W, Verberk IMW, Verfaillie SCJ, van den Bosch KA, van Leeuwenstijn M et al (2022) Association of CSF, plasma, and imaging markers of neurodegeneration with clinical progression in people with subjective cognitive decline. Neurology 98(13):e1315\u2013e1326","journal-title":"Neurology"},{"key":"12674_CR71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2017.06.002","volume":"58","author":"JB Pereira","year":"2017","unstructured":"Pereira JB, Westman E, Hansson O (2017) Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer\u2019s disease. Neurobiol Aging 58:14\u201329","journal-title":"Neurobiol Aging"},{"issue":"12","key":"12674_CR72","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","volume":"143","author":"AL Benedet","year":"2020","unstructured":"Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M et al (2020) Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease. Brain 143(12):3793\u20133804","journal-title":"Brain"},{"issue":"10","key":"12674_CR73","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s40520-022-02095-y","volume":"34","author":"F Nabizadeh","year":"2022","unstructured":"Nabizadeh F, Balabandian M, Rostami MR, Kankam SB, Ranjbaran F, Pourhamzeh M (2022) Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer\u2019s disease: results from ADNI. Aging Clin Exp Res 34(10):2363\u20132372","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"12674_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13195-019-0574-0","volume":"12","author":"P Parbo","year":"2020","unstructured":"Parbo P, Madsen LS, Ismail R, Zetterberg H, Blennow K, Eskildsen SF et al (2020) Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer\u2019s disease. Alzheimers Res Ther 12(1):3","journal-title":"Alzheimers Res Ther"},{"key":"12674_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104960","volume":"142","author":"SA Schultz","year":"2020","unstructured":"Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J et al (2020) Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer\u2019s disease. Neurobiol Dis 142:104960","journal-title":"Neurobiol Dis"},{"issue":"21","key":"12674_CR76","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","volume":"89","author":"PSJ Weston","year":"2017","unstructured":"Weston PSJ, Poole T, Ryan NS, Nair A, Liang Y, Macpherson K et al (2017) Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration. Neurology 89(21):2167\u20132175","journal-title":"Neurology"},{"issue":"4","key":"12674_CR77","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","volume":"16","author":"FM Elahi","year":"2020","unstructured":"Elahi FM, Casaletto KB, La Joie R, Walters SM, Harvey D, Wolf A et al (2020) Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement 16(4):681\u2013695","journal-title":"Alzheimers Dement"},{"issue":"1","key":"12674_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12291","volume":"14","author":"D Shir","year":"2022","unstructured":"Shir D, Graff-Radford J, Hofrenning EI, Lesnick TG, Przybelski SA, Lowe VJ et al (2022) Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer\u2019s disease and vascular pathology. Alzheimers Dement (Amst) 14(1):e12291","journal-title":"Alzheimers Dement (Amst)"},{"issue":"17","key":"12674_CR79","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","volume":"87","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Zetterberg H, Janelidze S, Insel PS, Andreasson U, Stomrud E et al (2016) Plasma tau in Alzheimer disease. Neurology 87(17):1827\u20131835","journal-title":"Neurology"},{"issue":"1","key":"12674_CR80","doi-asserted-by":"publisher","first-page":"16075","DOI":"10.1038\/s41598-019-52488-9","volume":"9","author":"M De Marco","year":"2019","unstructured":"De Marco M, Ourselin S, Venneri A (2019) Age and hippocampal volume predict distinct parts of default mode network activity. Sci Rep 9(1):16075","journal-title":"Sci Rep"},{"issue":"3","key":"12674_CR81","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.neurobiolaging.2010.04.013","volume":"33","author":"W Koch","year":"2012","unstructured":"Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde ALW et al (2012) Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer\u2019s disease. Neurobiol Aging 33(3):466\u2013478","journal-title":"Neurobiol Aging"},{"issue":"16","key":"12674_CR82","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.scib.2023.07.009","volume":"68","author":"F Gao","year":"2023","unstructured":"Gao F, Dai L, Wang Q, Liu C, Deng K, Cheng Z et al (2023) Blood-based biomarkers for Alzheimer\u2019s disease: a multicenter-based cross-sectional and longitudinal study in China. Sci Bull (Beijing) 68(16):1800\u20131808","journal-title":"Sci Bull (Beijing)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12674-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T15:04:25Z","timestamp":1731510265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12674-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":82,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["12674"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12674-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}